Maintenance therapies in late-life depression: MTLD III

Trial Profile

Maintenance therapies in late-life depression: MTLD III

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Sep 2016

At a glance

  • Drugs Donepezil (Primary) ; Antidepressants; Duloxetine; Escitalopram; Venlafaxine
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Acronyms MTLD-III
  • Most Recent Events

    • 07 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 07 Dec 2007 The expected completion date for this trial is now 1 Oct 2009.
    • 07 Dec 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top